LMT Medical, a subsidiary of Geratherm Medical AG, has received product approval for the Chinese market for its MRI-capable incubator system for newborns. The basis for the approval, which was granted over a period of five years, was, among other things, a successful clinical study conducted in China. With the LMT product, incubator system nomag(R) IC, premature and newborn infants can be examined directly in MRI - Magnetic Resonance Tomography - to diagnose any possible brain or organ damage. This is currently a unique solution worldwide. To date, more than 100 LMT Medical systems are in use worldwide. The approval will already have a positive impact on the company's sales development in 2021.